Herbert Kim Lyerly MD

Kim Lyerly

Core Faculty

Herbert Kim Lyerly, MD

Trotter TN, Dagotto CE, Serra D, Wang T, Yang X, Acharya CR, et al. Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3. JCI Insight. 2023 Nov 22;8(22).

Crosby EJ, Hartman ZC, Lyerly HK. Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets. Clin Cancer Res. 2023 Sep 1;29(17):3256–8.

Wilson BE, Sullivan R, Peto R, Abubakar B, Booth C, Werutsky G, et al. Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting. JCO Glob Oncol. 2023 Sep;9:e2300294.